Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/71831
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kriangkrai Chawansuntati | en_US |
dc.contributor.author | Kritsadee Rattanathammethee | en_US |
dc.contributor.author | Jiraprapa Wipasa | en_US |
dc.date.accessioned | 2021-01-27T04:16:28Z | - |
dc.date.available | 2021-01-27T04:16:28Z | - |
dc.date.issued | 2021-01-01 | en_US |
dc.identifier.issn | 15353699 | en_US |
dc.identifier.issn | 15353702 | en_US |
dc.identifier.other | 2-s2.0-85099352150 | en_US |
dc.identifier.other | 10.1177/1535370220981579 | en_US |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85099352150&origin=inward | en_US |
dc.identifier.uri | http://cmuir.cmu.ac.th/jspui/handle/6653943832/71831 | - |
dc.description.abstract | © 2021 by the Society for Experimental Biology and Medicine. The association between the presence of anti-interferon-γ autoantibodies and the onset of immunodeficiency with intracellular infections has been clearly established. No standard regimen to control the production of these pathogenic autoantibodies, apart from antimicrobial therapy to eliminate infections, contributes to the medical burden of this syndrome, which sometimes has a fatal outcome. In this review, we summarize the findings on anti-interferon-γ autoantibodies to facilitate further research and to provide guidance for treatment strategies. | en_US |
dc.subject | Biochemistry, Genetics and Molecular Biology | en_US |
dc.title | Minireview: Insights into anti-interferon-γ autoantibodies | en_US |
dc.type | Journal | en_US |
article.title.sourcetitle | Experimental Biology and Medicine | en_US |
article.stream.affiliations | Chiang Mai University | en_US |
Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.